Jounce Therapeutics Inc buy Slaandjivaa
Start price
14.03.17
/
50%
€19.65
Target price
24.03.17
€25.26
Performance (%)
17.43%
End price
24.03.17
€23.07
Summary
This prediction ended on 24.03.17 with a price of €23.07. The prediction had a final performance of 17.43%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Jounce Therapeutics Inc | - | - | - | - |
iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
Comments by Slaandjivaa for this prediction
In the thread Jounce Therapeutics Inc diskutieren
Unschlaff
Achten:
http://seekingalpha.com/article/4054590-buy-shares-lesser-known-celgene-partner
(Vom Mitglied beendet)